
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
BenevolentAI is a pioneer and leader in applying advanced explainable AI to drug discovery and development. In a world where the drug development failure rate still exceeds 90% and thousands of complex diseases lack effective treatment, our technology can increase the probability of success and reduce timelines. Our proprietary Benevolent PlatformTM is one of the industrys most established and validated AI drug discovery technologies. In 2020, it took our scientists just 48 hours to identify baricitinib as a potential treatment for COVID-19. This became the first AI-identified drug indication to receive full FDA approval. Our expertise in target identification and...
Artificial intelligence,drug development,scientific innovation,machine learning,deep learning,big data,pharmaceutical,biopharma,and drug discovery
Benevolentai operates in the Biotechnology research industry.
Benevolentai's revenue is 1m - 10m
Benevolentai has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.